The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.05
Bid: 2.90
Ask: 3.20
Change: -0.05 (-1.61%)
Spread: 0.30 (10.345%)
Open: 3.10
High: 3.10
Low: 3.05
Prev. Close: 3.10
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Thu, 20th May 2021 16:07

Friday 21 May 
Arrow Global Group PLCGM re acqusition by Sherwood Acquisitions Ltd
Central Asia Metals PLCAGM
Circassia Group PLCAGM
Croda International PLCAGM
Fair Oaks Income LtdAGM
Headlam Group PLCAGM
Old Mutual LtdAGM
Premier African Minerals LtdAGM
Secure Income REIT PLCAGM
Monday 24 May 
4D Pharma PLCAGM
Ashoka India Equity Investment Trust PLCGM re new share issuance programme
Blackbird PLCAGM
CloudCall Group PLCAGM
Energean PLCAGM
Hilton Food Group PLCAGM
Tuesday 25 May 
Aston Martin Lagonda Global Holdings PLCAGM
Bank of Cyprus Holdings PLCAGM
Bank of Georgia Group PLCAGM
Bank of Ireland Group PLCAGM
Edenville Energy PLCGM re fundraising
Empiric Student Property PLCAGM
Epwin Group PLCAGM
Georgia Capital PLCAGM
Harworth Group PLCAGM
Hill & Smith Holdings PLCAGM
Logistics Development Group PLCAGM
Marlowe PLCGM re approval on remuneration policy
Mortgage Advice Bureau Holdings PLCAGM
OSB Group PLCAGM
Quarto Group IncAGM
Restaurant Group PLCAGM
Riverstone Energy LtdAGM
Serabi Gold PLCAGM
Yew Grove REIT PLCAGM
Wednesday 26 May 
Anglo Pacific Group PLCAGM
Arbuthnot Banking Group PLCAGM
Bango PLCAGM
Coca-Cola European Partners PLCAGM
Deltic Energy PLCAGM
Equiniti Group PLCAGM
eve Sleep PLCAGM
Fundsmith Emerging Equities Trust PLCAGM
Intertek Group PLCAGM
JTC PLCAGM
Judges Scientific PLCAGM
Keywords Studios PLCAGM
Life Settlement Assets PLCGM re merger of A and B shares
M&G PLCAGM
Playtech PLCAGM
Rambler Metals & Mining PLCAGM - vote on share consolidation
Sherborne Investors (Guernsey) B LtdAGM
Sherborne Investors (Guernsey) C LtdAGM
Zotefoams PLCAGM
Thursday 27 May 
BMO Private Equity Trust PLCAGM
Bodycote PLCAGM
Bonhill Group PLCAGM
Cambridge Cognition Holdings PLCAGM
Curtis Banks Group PLCAGM
Deltex Medical Group PLCAGM
Ferrexpo PLCAGM
Glenveagh Properties PLCAGM
Great Western Mining Corp PLCAGM
Hochschild Mining PLCAGM
Inchcape PLCAGM
Independent Investment Trust PLCAGM
International Public Partnerships LtdAGM
Nucleus Financial Group PLCAGM
Oxford BioMedica PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
ValiRx PLCAGM
Vectura Group PLCAGM
Vectura Group PLCGM re special dividend, share consolidation
Xeros Technology Group PLCAGM
XLMedia PLCAGM
Yu Group PLCAGM
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
26 Mar 2019 10:22

ValiRx Notes ValiSeek Co-Financing Deals For VAL401 Cancer Drug

LONDON (Alliance News) - Biotechnology firm ValiRx PLC on Tuesday said ValiSeek has secured letters of intent from two companies to co-finance the development of cancer drug VAL401.Shares a

Read more
21 Mar 2019 09:53

ValiRx Notes Encouraging Performance Of VAL201 In Cancer Trial

LONDON (Alliance News) - ValiRx PLC on Thursday said an interim inspection of its VAL201 early phase cancer trial shows the drug is performing as predicted.Shares in ValiRx were up 13% at a

Read more
21 Feb 2019 12:46

ValiRx Raises GBP500,000 Through Placing To Advance Clinical Trials (ALLISS)

LONDON (Alliance News) - ValiRx PLC on Thursday raised GBP500,000 through a share placing to expand its clinical trial of VAL201, as well as the VAL301 and VAL101 programmes.ValiRx issued a

Read more
31 Jan 2019 13:37

ValiRx Secures Patent For VAL301 Compound In Russia And China

LONDON (Alliance News) - ValiRx PLC on Thursday said it has been granted a patent allowance for its therapeutic compound VAL301 in both Russia and China.The clinical stage biotechnology has

Read more
31 Jan 2019 10:08

ValiRx allowed patents for VAL401 in Russia and China

(Sharecast News) - Clinical-stage biotechnology company ValiRx announced on Thursday that the patent offices of Russia and China had both granted a patent allowance for its pre-clinical therapeutic compound, VAL301, subject to payment of the relevant fees.

Read more
9 Jan 2019 14:57

ValiRx gives NHS Long Term Plan its seal of approval

(Sharecast News) - Clinical stage biotechnology company ValiRx endorsed the Government's new NHS Long Term Plan to improve the quality of patient care and health outcomes on Wednesday.

Read more
9 Jan 2019 11:25

ValiRx Backs New Long-Term UK Government Plan For NHS

LONDON (Alliance News) - Biotechnology firm ValiRx PLC on Wednesday said it endorses the UK government's new NHS long-term plan."The government's recently announced ten-year a

Read more
18 Dec 2018 15:53

VAL401 results accepted for journal publication, says ValiRx

(Sharecast News) - Clinical stage biotechnology company ValiRx announced the acceptance for publication of the first article containing results from the VAL401 clinical trial by the European Journal of Drug Metabolism and Pharmacokinetics on Tuesday.

Read more
10 Dec 2018 11:07

ValiRx releases positive data from recent VAL201 testing

(Sharecast News) - Clinical stage biotechnology company ValiRx announced on Monday that independent analysis of VAL201 data showed a "statistically significant" dose dependant response in the reduction of PSA correlated to time on the Phase l/ll clinical trial, involving patients with hormone-sensitive and hormone-resistant prostate cancer.

Read more
10 Dec 2018 10:59

WINNERS & LOSERS SUMMARY: Just Group Jumps 23% On Regulatory Decision

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------NMC up The

Read more
10 Dec 2018 09:06

ValiRx Reports Positive VAL201 Effect On Patients With Prostate Cancer

LONDON (Alliance News) - ValiRx PLC on Monday said an independent analysis of VAL201 showed a positive effect on patients with hormone-sensitive and hormone-resistant prostate cancer.The up

Read more
17 Oct 2018 08:36

ValiRx enters finals stages of clinical trials on VAL201

(Sharecast News) - Clinical stage biotechnology company ValiRx's leading anti-cancer therapeutic has entered the concluding stages of its Phase l/ll clinical trial at University College London Hospital.

Read more
25 Sep 2018 13:23

ValiRx Half Year Loss Widens On Expenses And Share Option Charge

LONDON (Alliance News) - Life science company ValiRx PLC on Tuesday reported a widened loss in the first half of 2018 due to expenses and a sizeable share option charge.The company's to

Read more
6 Sep 2018 11:38

ValiRx Says Clinical Study For Lung Cancer Drug VAL401 Is Approved

LONDON (Alliance News) - Clinical stage biotechnology company ValiRx PLC said Thursday its clinical study report on lung cancer drug VAL401 has been signed and approved by principal in ValiRx were

Read more
6 Sep 2018 09:05

ValiRx enters 'very exciting' phase for cancer therapies

(Sharecast News) - ValiRx told investors on Thursday that its clinical-stage therapeutics had continued to demonstrate "significant potential" for addressing unmet medical needs in oncology.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.